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Abstract 7 
To test whether an association exists between radon gas concentration in the home and increased 8 
multiple sclerosis (MS) incidence, a retrospective study was undertaken of MS incidence in known 9 
areas of raised domestic radon concentration in England and Wales, using The Health Improvement 10 
Network (THIN) clinical research database. 11 
The study population comprised 20,140,498 person-years of clinical monitoring (males: 12 
10,056,628: 49.93%; females: 10,083,870: 50.07%), representing a mean annual population of 2.5 13 
million individuals. To allow for the possible latency of MS initiation following exposure, data 14 
extraction was limited to patients with at least five years registration history with the same GP 15 
practice before first diagnosis. Patient records were allocated to one of nine radon concentration 16 
bands depending on the average radon level in their postcode sector. 17 
MS incidence was analysed by searching for patients with first MS diagnosis over the eight 18 
calendar years 2005 to 2012 inclusive. 1,512 new MS cases were diagnosed, 1,070 females, 442 19 
males, equivalent to raw incidence rates of 7.51, 10.61 and 4.40 per 105 person-years respectively, 20 
comparable to previously reported results. Of these new cases, 115 could be allocated to one of the 21 
radon bands representing high radon areas. 22 
Standardising to the UK 2010 population, excess relative risk (ERR) figures for MS were calculated 23 
for each radon band. Linear regression of ERR against mean band radon concentration shows a 24 
positive gradient of 0.22 per 100 Bq.m-3 (R2 = 0.25, p = 0.0961) when forced through the origin to 25 
represent a linear-no-threshold response. The null hypothesis falls inside the 95% confidence 26 
interval for the linear fit and therefore this fit is not statistically significant. We conclude that, 27 
despite THIN sampling around 5% of the population, insufficient data was available to confirm or 28 
refute the hypothesised association between MS incidence and radon concentration. 29 
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Is Environmental Radon Gas Associated with the Incidence of Neurodegenerative 1 
Conditions? A Retrospective Study of Multiple Sclerosis in Radon Affected Areas in 2 
England and Wales 3 
1 Introduction 4 
1.1 Environmental Radon Gas 5 
1.1.1 Origins 6 
Radon, a naturally occurring radioactive gaseous decay product of uranium, is widely distributed in 7 
the environment in rocks and soils, with varying geographical concentration, and in building 8 
materials incorporating or manufactured from these. On generation, radon migrates to the 9 
atmosphere by diffusion and convection, giving a mean outdoor air concentration in the British Isles 10 
in the range 4 – 6 Bq·m-3 (Wrixon et al., 1998; Gunning et al., 2014). Although radon dissipates 11 
rapidly in outdoor air, it concentrates in the built environment, typical ingress routes being cracks in 12 
walls and floors, and drains and loose-fitting pipes, the mean UK domestic radon concentration 13 
being around 20 Bq·m-3 (Wrixon et al., 1998).  14 
1.1.2 Physiology and Health 15 
The most significant radon isotope, 222Rn, decays by α-emission (half-life 3.8 days) via 218Po and 16 
214Bi (both also α-emitters) to 210Po, the final decay product being the stable lead isotope 206Pb. 17 
These heavy-metal daughters, all highly toxic and readily adsorbed onto atmospheric particles and 18 
lung tissue, pose a significant health hazard, inhalation of 222Rn and its progeny providing the 19 
majority of the radiation dose received by the respiratory system (Darby et al., 2001). A direct 20 
consequence of the trapping of radon decay products in the lung has been the association between 21 
enhanced levels of environmental radon and increased risk of lung-cancer, leading to recognition of 22 
radon as a significant factor in the incidence of lung-cancer among smokers (BEIR, 1999). 23 
Radon, nearly two orders of magnitude more soluble in polar hydrocarbons than in water, is lipid-24 
soluble, its solubility depending on the  number of carbon atoms per lipid molecule and peaking in 25 
the region of heptanoic acid at a level 7.4 times that in ambient air (Lykken and Momčilović, 2003, 26 
2006). Radon forms clathrates with water and alcohols, both abundant in animal tissue. Although 27 
most inhaled radon is immediately exhaled, some becomes trapped in the lungs and migrates to the 28 
blood-stream, where it is soluble at a level of 42% of its solubility in water at 310 K (Knaffl-Lenz, 29 
1912; IUPAC, 1979), moving freely around the body, including into and out of the brain despite the 30 
blood-brain barrier. In contrast, radon’s lipid-insoluble neurotrophic and neurotoxic heavy-metal 31 
decay products remain trapped at the locations where they are generated, acting as localised sources 32 
of radioactivity and heavy-metal toxicity, causing radiation damage and chemical injury to body 33 
cells. 34 
1.1.3 Geographical Occurrence 35 
Environmental radon concentration levels are geographically variable in response to local 36 
geological conditions, and may fluctuate significantly across relatively small distances. This is 37 
particularly true in the British Isles, which possess a complex geology extending continuously from 38 
the Pre-Cambrian to the Holocene. In mainland Britain, the highest domestic radon concentration 39 
levels are associated with the granite of the south-west peninsula (Devon and Cornwall). Elevated 40 
radon levels also occur along the Jurassic escarpment crossing the Midlands from Somerset to 41 
Lincolnshire, in the Derbyshire Peak District, and in well-defined localities in the Welsh borders 42 
and in Aberdeenshire in Scotland. In Ireland, high radon areas are distributed principally along the 43 
South-East and North-West coastal areas, with outliers in Co. Kerry in the Republic of Ireland (RoI) 44 
and in Co. Armagh in Northern Ireland. Figure 1 compares (a) the geographical distribution of 45 
radon across the UK (NRPB, 2000) and (b) an indication of the complex bedrock geology 46 
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underlying the observed radon variability generated using Make-a-Map (BGS, 2015), an interactive 1 
online geological map of the British Isles provided by the British Geological Survey 1. 2 
Radiation protection in England and the Devolved Administrations (Scotland, Wales and Northern 3 
Ireland) within the United Kingdom (UK), formerly administered by the National Radiological 4 
Protection Board (NRPB), is currently the responsibility of the Centre for Radiation, Chemical and 5 
Environmental Hazards2 (CRCE), lately part of the UK Health Protection Agency (HPA) and now a 6 
division of Public Health England. The Radiological Protection Institute of Ireland (RPII) fulfils the 7 
same function in the RoI. Responding to the health threat posed by domestic radon in the UK, the 8 
NRPB initially established a residential Action Level of 200 Bq·m−3 (NRPB, 1990), declaring as 9 
Radon Affected Areas (RAAs) those geographical entities where over 1% of domestic 10 
measurements showed radon concentrations above the Action Level. Initially comprising Devon, 11 
Cornwall, parts of Somerset, Northamptonshire and Derbyshire, subsequent study by NRPB and its 12 
successors has identified further RAAs in England and Wales, with increasingly enhanced 13 
geographical resolution (Miles et al., 1996). Numerical and cartographical data on RAAs are 14 
published in the Radon Atlas for England and Wales (Green et al., 2002; Miles et al., 2007, Rees et 15 
al., 2010), reporting radon levels at scales ranging from county to postcode sector. Corresponding 16 
atlases are published by CRCE for Scotland (Miles et al., 2011) and Northern Ireland (Daraktchieva 17 
et al., 2015), and by RPII for the RoI (Fennell et al., 2002; Hodgson et al., 2014).  18 
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 (a) (b) 39 
Figure 1: (a) Distribution of domestic radon across the United Kingdom (NRPB, 2000). 40 
Units Bq·m-3. 41 
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 (b) Simplified bedrock geology of the British Isles. Source: BGS Make-a-Map. Online 1 
at: http://www.bgs.ac.uk/discoveringgeology/geologyofbritain/makeamap/home.html 2 
Reproduced with the permission of the British Geological Survey ©NERC. All Rights 3 
Reserved. 4 
Research has identified substantial geographical variability in domestic radon concentrations, 5 
demonstrating spatial correlation between mean annual radon concentration and the underlying 6 
geology, and studies of the influence of radon on the incidence of radon-induced conditions, 7 
principally cancers and cancer-related diseases, have been reported. Metadata analysis of thirteen 8 
European case-control studies (Darby et al., 2005) demonstrated the excess relative risk (ERR) of 9 
residential radon-induced lung-cancer to be 0.16 per 100 Bq·m-3 (95% C.I. 0.05 – 0.31). A 10 
contemporaneous North American study (Krewski et al., 2005) reported ERR of 0.18 per 11 
100 Bq·m-3 (95% C.I. 0.02 – 0.43), compatible with the previous ERR estimate from the same team 12 
of 0.12 (Lubin et al., 1997), predicted by extrapolation from the earlier Colorado Miners studies 13 
(Lubin et al., 1995). Independent meta-analysis of seventeen studies worldwide (Pavia et al., 2003), 14 
some of which formed the basis of the later, more focussed, studies, reported ERR at 150 Bq·m-3 of 15 
0.24 (95% C.I. 0.11 – 0.38), equivalent to 0.16 per 100 Bq·m-3. More recently, a Canadian 16 
population-based case-control study (Hystad et al., 2014) found positive association between lung-17 
cancer incidence and domestic radon exposures derived from maps, with ERR of 0.13 per 18 
100 Bq·m-3 (95% C.I. -0.12 – 0.46). 19 
Although epidemiological studies have confirmed a link between domestic radon exposure and 20 
increased lung-cancer risk, with further studies suggesting that other cancers, especially leukaemia, 21 
kidney cancer, and malignant melanoma, are related to indoor radon, direct radon causality of other 22 
cancers has not been convincingly demonstrated. The current view is that if radon and its decay 23 
products do have carcinogenic effects on organs other than the lung, then the effect is so weak as to 24 
be generally undetectable in the published epidemiological studies (AGIR, 2009). 25 
1.2 Multiple Sclerosis and Radon  26 
In addition to lung-cancer and related conditions, environmental radon exposure has been 27 
postulated to be responsible for the triggering, often late in life, of certain neurodegenerative 28 
conditions, including Alzheimer’s and Parkinson’s diseases (Momčilović et al., 2001), motor 29 
neurone disease (Nielson et al., 1996), and multiple sclerosis (MS) (Bølviken et al., 2003; Eidbo 30 
and Prater, 2004; Gilmore and Grennan, 2003; Neuberger et al., 2011). Pilot studies of the influence 31 
of geographic variability, and hence, indirectly, of the influence of local radon concentration, on the 32 
incidence of non-cancer conditions, particularly MS, have been reported, and are discussed in more 33 
detail subsequently. 34 
1.2.1 Aetiology and Prevalence 35 
Multiple sclerosis, a disorder of the central nervous system, manifests as acute focal inflammatory 36 
demyelination and axonal loss with limited re-myelination, culminating in the chronic multifocal 37 
sclerotic plaques from which the disease gets its name (Compston and Coles, 2003). On a global 38 
scale, prevalence increases with latitude in both hemispheres (Kurtzke, 2000; Simpson et al., 2011), 39 
with broad areas of Africa and Asia relatively unaffected. MS is the most common cause of serious 40 
neural disability in young adults in the UK, with exposure to some environmental agent before the 41 
age of 15 years being postulated as a factor in its later development in genetically susceptible 42 
individuals (Compston et al., 1998). Belbasis et al. (2015), in a recent umbrella review of 43 
systematic reviews and meta-analyses of environmental risk factors, noted that the causes of MS are 44 
still largely unknown. Early studies of MS in the UK were supportive of an increasing latitudinal 45 
gradient between the south of England and the north of Scotland (Swingler and Compston, 1986). 46 
Re-analysis of earlier results suggests that evidence for a latitudinal gradient within England is less 47 
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convincing (Robertson and Compston, 1995), although increased prevalence remains in Scotland 1 
compared with England and Wales (Forbes and Swingler, 1999).  2 
1.2.2 Possible Mechanism for Radon 3 
The oligodendrocyte, a principal target of immune attack in MS, synthesises and maintains the 4 
myelin sheath of up to 40 neighbouring nerve axons in the central nervous system. Compact myelin 5 
consists of a condensed membrane, spiralled around axons to form the insulating segmented sheath 6 
needed for saltatory axonal conduction. In MS, the lipoproteins of the myelin sheaths around the 7 
axon of the nerve cell are lost in a degenerative process of demyelination, severely affecting 8 
saltatory conduction. Lykken and Momčilović (2003a, 2003b) proposed that myelin sheath lipids 9 
take up inhaled lipid-soluble environmental radon; in this delicate and sensitive environment, 10 
subsequent α- and β-particle bombardment irreversibly damages myelin cell nuclei, puncturing the 11 
myelin sheaths beyond the point of repair and causing permanent nerve impulse propagation failure. 12 
An additional outcome of this irradiation is free-radical generation, leading to potential peroxidative 13 
damage to the myelin lipid portion (Cooper, 1997). Together with other studies (Hursh et al., 1965; 14 
Nussbaum and Hursh, 1965), this potentially provides a mechanism for delivering a significant 15 
radiation dose to the cells involved in MS. 16 
1.2.3 Ecological Studies 17 
A number of northern-hemisphere ecological studies suggest a possible correlation between 18 
domestic radon levels and MS, with higher incidence identified in regions with higher mean 19 
domestic radon concentrations. 20 
In Ireland, MS prevalence in the mountainous north-west, an area with extensive high-uranium 21 
granite bedrock geology and high radon-emission, is among the highest in the island. Good county-22 
by-county correlation was observed between mean radon level and the membership level of MS-23 
Ireland, with lowest prevalence across the Midlands (Gilmore and Grennan, 2003). A questionnaire 24 
survey showed that MS sufferers in the north-west were more likely to be living in their childhood 25 
home or its locality, and more likely to live in homes with private (well) water supplies, both factors 26 
implying potential higher lifetime radon exposure. Extending this study, Carroll (2005) observed 27 
MS clustering in high-radon areas, with sparser distribution in low-radon areas, concluding that the 28 
potential for MS development is greater with higher childhood radon exposure, especially among 29 
males, and that the observed increased incidence since the 1970s coincides with greater exposure to 30 
indoor radon, due to improvements in the housing stock. 31 
Using spatially-moving bivariate correlation, Bølviken et al. (2003) studied MS mortality in 73 32 
rural municipality aggregates in Norway, demonstrating positive correlation (p <0.01) between MS 33 
and indoor air radon content, and negative correlation (p <0.01) with precipitation and magnesium 34 
fallout. Under their hypothesis, air-borne radon levels are influenced by atmospheric fall-out of 35 
magnesium and other marine-origin elements through their ion-exchange with the radon precursor, 36 
radium, and by annual precipitation through its effect on soil moisture and outwash of radium and 37 
related constituents in the soil. Some of the epidemiological characteristics of MS were shown to be 38 
not incompatible with observed environmental conditions, with plausible explanations of the role of 39 
environmental radon being offered. 40 
A latitudinal MS prevalence gradient exists in the USA, ranging from 57 per 105 in the south to 150 41 
per 105 in the north (NMSS, 1994). Following identification of elevated radon concentrations in 92 42 
of the 99 counties in Iowa, Eidbo and Prater (1994) confirmed correspondingly high MS 43 
prevalence, using National Multiple Sclerosis Society (NMSS) membership data. Similar 44 
correlations, also using NMSS data, were subsequently identified in Idaho, Minnesota and 45 
Washington (Eidbo and Prater, 2004). In Washington state, the highest prevalence (255 per 105) 46 
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was found in Spokane county, which had the highest radon exposure in the state; King county, with 1 
the lowest MS prevalence (121 per 105), is the lowest radon exposure region. 2 
In North Dakota, Lykken et al. (2008) analysed ambient air radon and whole body retention of a 3 
radon daughter (214Bi) from the bedrooms of fifteen MS subjects and fifteen controls with no 4 
apparent health problems. Preliminary data indicated that bedroom 222Rn exposure and 214Bi 5 
retention were higher in the MS subjects than in the controls. 6 
Neuberger et al. (2011), also noting the latitudinal MS-prevalence and residential radon gradients in 7 
the USA, reported a pilot case-control study involving 97 MS patients diagnosed for less than 5 8 
years, and 51 non-MS controls. Although they identified a trend in the radon measurements in the 9 
homes of a sub-group resident in one home for at least five years prior to diagnosis, suggesting an 10 
increased probability of radon exposure, it did not reach statistical significance (Odds Ratio = 1.98; 11 
95% CI = 0.98 - 3.98, p =0.06), the small sample size being deemed a limiting factor. 12 
In a study to assess whether other ionising radiation sources are associated with MS, Axelson et al. 13 
(2001) demonstrated correlation between MS and both occupational (Odds Ratio = 4.4, 95% CI 1.6 14 
- 11.6) and diagnostic (Odds Ratio = 1.8, 95% CI 1.2 - 2.6) X-ray exposure from two areas of 15 
southern Sweden. Cases were noted where X-ray examination of MS patients accelerated 16 
demyelination, suggesting firstly, that ionising radiation bombardment triggers demyelination in 17 
susceptible individuals (Peterson et al., 1993) and, secondly, that radiation-induced free-radical 18 
generation and oxidative damage are of importance in MS pathogenesis (Cooper, 1997). 19 
2 Method 20 
2.1 Hypothesis 21 
This study tested the hypothesis that association exists between local domestic radon concentration 22 
and MS incidence, by comparing MS diagnosis data, obtained anonymously from patient records 23 
held by General Practitioners (GPs) in England and Wales, to the known geographical variation of 24 
radon, tabulated by postcode sector in the Radon Atlas of England and Wales (Green et al., 2002). 25 
A preliminary estimate of the expected patient numbers and the statistical power of the proposed 26 
analysis, made prior to commencing the study, indicated that, for the eight years of incidence data, 27 
sufficient statistical power was potentially available to justify the exercise. 28 
2.2 Study Design 29 
This was a retrospective population-based study using the clinical database maintained by The 30 
Health Improvement Network (THIN)3, a computerised longitudinal GP database with demographic 31 
scope similar to that of the overall UK population (Bourke et al., 2004). The THIN data recording 32 
scheme, initially developed from the General Practice Research Database (GPRD) (Walley and 33 
Mantagini, 1997) under a non-exclusive license, collects anonymised clinical data from 34 
collaborating practices that use the Vision 360 practice management software4, following agreed 35 
protocols to preserve anonymity, and collates and organises this information for research purposes. 36 
Vision is currently used by approximately 20% of GPs in England, 30% in Scotland and Northern 37 
Ireland and just over 50% in Wales. 38 
THIN contains the medical records of 12.4 million patients, 3.6 million of whom are currently 39 
registered with a practice and who can be followed prospectively; retrospective data are available 40 
for the remaining patients who have either died or transferred from THIN practices. This is 41 
equivalent to 85.8 million patient-years of data from 587 general practices in the UK, covering 42 
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5.67% of the UK population (2013 figures, national breakdown unavailable) (IMS Health, 2015). 1 
Patient data in THIN, including clinical notes, referrals, downloaded test results, prescriptions and 2 
demographics, are catalogued using Read Codes (Bentley et al., 1996), complemented by Multilex5 3 
codes identifying prescribed medications. All patient data extracted from practice database systems 4 
are fully anonymised and validated and are representative of the entire UK population and each 5 
National Health Service (NHS) region (Blak et al., 2011). 6 
2.2.1 Domestic Radon Concentration Database 7 
Radon concentration data for England and Wales are publicly available in the Radon Atlas for 8 
England and Wales (Green et al., 2002; Miles et al., 2007; Rees et al., 2010), which reports radon 9 
concentration levels in administrative and geographical units at granularities ranging from postcode 10 
sector to county.  11 
This study utilised data at postcode sector level, the finest granularity available. UK postcodes 12 
follow a hierarchical system (Area, District, Sector, Unit), comprising two alpha-numeric text 13 
components separated by a space, a typical example for Northamptonshire being NN1 2AB. The 14 
code component before the space, the Outward code, directs mail from the originating sorting office 15 
to the destination sorting office, while the component after the space, the Inward code, sorts mail 16 
into individual delivery rounds. In the Northamptonshire example, the initial pair of letters of the 17 
outward code (NN) represents the Northampton Area, while the following digit or digits represent 18 
the District (1, corresponding to the central area of Northampton town) within that area. The first 19 
component of the inward code (2 in this example, representing part of the central business area) 20 
defines the Postcode Sector, which usually contains several thousand individual addresses 21 
depending on the locality, with an average area across the UK of 22 km2. The final component, AB 22 
in this example, may represent between ten and twenty residential addresses or a single business 23 
address. 24 
In addition to arithmetic and geometric mean radon levels, the Atlas tabulates total numbers of 25 
homes in each geographical unit with the corresponding number of homes tested for radon, and 26 
projects the percentage of homes anticipated to show mean annual radon concentration levels 27 
exceeding the UK Action Level of 200 Bq·m-3. For confidentiality, the Atlas does not publish data 28 
for areas where few (<10) measurements have been made. To further improve the estimates of 29 
average radon concentration, only postcode sectors where at least 50 houses had been tested were 30 
considered here, reducing the potentially usable dataset to around 50% of the total housing tested 31 
for radon in England and Wales. 32 
Using the published data, each postcode sector reporting results from 50 or more radon 33 
measurements was assigned to one of nine radon bands, defined by the percentage of homes in that 34 
sector with radon levels above the 200 Bq·m-3 Action Level. Band 1 contained postcode sectors 35 
with between 0 and 1% of measured homes with radon concentrations above the Action Level. 36 
Bands 2 to 9 correspond to the RAAs (NRPB, 1990). Table 1 summarises the radon band 37 
allocations, together with the corresponding numbers of houses tested and the annual mean radon 38 
concentration for each band, weighted to compensate for the numbers of homes in each postcode 39 
sector. Geographically, the radon bands represent groups of spatially-distributed, potentially 40 
discontinuous areas, chosen to ensure approximately equal sample size in each of the nine groups. 41 
All postcode sectors represented in the THIN database but not appearing in the Radon Atlas, along 42 
with all sectors appearing in the Radon Atlas but with less than 50 radon measurements, were 43 
allocated to Band 0; incomplete data records were allocated to a further Band 10, the contents of 44 
which (68,066 records comprising 2.82% of the total 20,137,547 person-years encompassed by the 45 
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study) were discarded in subsequent analysis. Figure 2, generated using the open-source mapping 1 
software QGIS (2015), indicates the geographical spread of the radon bands on a map of British 2 
postcode sectors. 3 
 4 
Figure 2: Geographical distribution of postcode sectors comprising Radon Bands 0 – 9. 5 
Contains Ordnance Survey data © Crown copyright and database right 2012. Contains 6 
Royal Mail data © Royal Mail copyright and database right 2012. Contains National 7 
Statistics data © Crown copyright and database right 2012. 8 
2.2.2 Case Identification 9 
The resultant dataset was interrogated to extract the numbers of patients diagnosed with MS 10 
(numerator population) and total patient numbers (denominator population). The principal clinical 11 
search criteria, listed in Table 2, were Read Code F20, its subsidiaries and a further set of related 12 
codes. To ensure that any relevant radon exposure was received in the patient’s current home, and 13 
assuming that radon-induced MS initiation might replicate radon-induced lung-cancer, characterised 14 
by a linear-no-threshold process (BEIR, 1999; Darby et al., 2005) with latency period of the order 15 
of five years (Field et al., 2000), interrogation was limited to those patients with at least five years 16 
of registration history with the same general practice before first diagnosis. 17 
Data interrogation was carried out for England and Wales separately for each year of the period 18 
2005 to 2012 individually, with output presented as annual country-specific tables of incidence for 19 
males and females, classified by radon band and age. To generate a sufficiently large population for 20 
reliable subsequent statistical analysis, the results from these eight years and from the two 21 
geographic entities were combined. Modelling based on the known geographic incidence of 22 
environmental radon gas, the variation of lung-cancer incidence with radon, and the relative overall 23 
incidence figures for lung-cancer and MS, suggested that the study might identify 156 new MS 24 
diagnoses in RAAs during the eight-year period. 25 
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3 Results 1 
3.1 Study Population 2 
The study population was defined as those individuals identified from their residential address as 3 
living in a postcode sector situated in one of the radon bands defined in Table 1, and whose medical 4 
records were held in one of the GP databases participating in THIN. Overall, this represented 5 
20,140,498 person years of clinical monitoring, distributed approximately equally between males 6 
(10,056,628: 49.93%) and females (10,083,870: 50.07%). 7 
Although the Radon Atlas reports the number of homes within each geographical measurement unit, 8 
no data are available in this source regarding populations in each area. Assuming average household 9 
size of 2.47 across England and Wales (ONS, 2011), Figure 3 compares on a band-by-band basis 10 
the normalised population derived from the Radon Atlas and the correspondingly normalised THIN 11 
base population. Chi-squared testing confirmed (χ2 > 0.99) these distributions to be essentially 12 
identical. 13 
 14 
Figure 3: Population profiles of radon bands 15 
 Hatched bars – THIN base population 16 
 Solid bars – homes tabulated in Radon Atlas 17 
Using standard age-bands, Figure 4 compares the normalised age profile within the base population 18 
with the corresponding age profile of the population of England and Wales (E&W) in the year 2010 19 
(ONS, 2011). While the five-year registration condition inevitably makes direct comparison 20 
difficult, the reduced presence of individuals aged 20 - 30 years in the extracted data, possibly due 21 
to the additional mobility of this age group, which encompasses students and young adults taking 22 
up their first employment, deserves notice and highlights the need for care in comparisons. 23 
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 1 
Figure 4: Age profiles of populations 2 
 Hatched bars – THIN base population 3 
 Solid bars - England and Wales (mid-2010) (ONS, 2011) 4 
3.2 Raw MS Incidence 5 
A total of 1,512 new MS cases were diagnosed, from a mean annual population of around 2.5 6 
million people. Females (1,070 cases) outnumbered males (442 cases) by a factor of 2.42, 7 
comparable with the factor of 2.38 found by Mackenzie et al. (2014) in their recent review of MS 8 
incidence  in the UK. Of the 1,512 new cases, just 115 could be allocated to one of the radon bands 9 
representing RAAs, compared with the 156 expected from the modelling referred to above. 10 
Using corresponding data for MS diagnoses (numerators) and source population (denominators), 11 
raw incidence rates (population fraction diagnosed with MS per 105 person-years) were derived for 12 
each year/patient-age/radon-band locus. Table 3 summarises the raw output data aggregated over 13 
the study period for England and Wales combined, presenting MS incidence and underlying 14 
population for males, females and the total population. Results for the full population, Table 3(a), 15 
and for the subset of validated residents of the radon bands, Table 3(b), are shown separately. 16 
Raw incidence rates among the overall population were 10.61 and 4.40 per 105 person-years for 17 
females and males respectively, with an overall population incidence of 7.51 per 105 person-years. 18 
Among the validated residents of radon band areas, the corresponding figures were 11.30 and 4.67 19 
per 105 person-years for females and males respectively, with an overall population incidence of 20 
7.89 per 105 person-years. These are, respectively, 6.60%, 4.54% and 5.05% greater than the figures 21 
from the base population. Raw incidence data from the base population (Table 3(a)) are shown 22 
graphically in Figure 5. The distribution of incidence across the age-bands and between the genders 23 
is comparable in form with that found nationally in previous studies (Bray, 2002; Mackenzie et al., 24 
2014). 25 
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 1 
Figure 5: Age distribution of MS incidence among the full study population (Bands 0 – 9) 2 
 Dashed line/solid circles (red): Female 3 
 Chain line/open squares (blue): Male 4 
 Continuous line (black)  Full population 5 
Raw MS incidence was standardised to both the 2010 England and Wales Population (Bray, 2002) 6 
allowing comparison with previous MS incidence studies in these countries, and to the Standard 7 
World Population (Segi, 1960), facilitating comparison with international studies. Standardising to 8 
the 2010 England and Wales population gives incidence of 11.43 per 105 person-years for females, 9 
4.88 per 105 person-years for males and 8.12 per 105 person-years overall. As Table 4 shows, these 10 
results show good agreement with those of a recent evaluation of MS incidence in the UK over the 11 
period 1990 to 2010 (Mackenzie at al., 2014); this utilised the GPRD (Walley and Mantagini, 12 
1997), an alternative extraction of GP records, with coverage comparable to that of THIN. Both 13 
studies show higher incidence than those obtained by Alonso et al. (2007) in their UK investigation 14 
covering the period 1993 to 2010, again using the GPRD. 15 
3.3 MS Incidence and Radon Concentration Level 16 
Table 3 summarises the identified cases and corresponding base populations, by individual radon 17 
band, along with overall population estimates derived from the Radon Atlas and assuming a mean 18 
household occupancy of 2.47. With the exception of Band 9, which encompassed just 14 person-19 
years and returned no new MS diagnoses during the study period, the proportion of the Radon Atlas 20 
population sampled by THIN was moderately consistent, ranging from 2.35% to 4.31%. 21 
Using both raw and population-corrected data, MS incidence rates were determined for each radon 22 
band. Results are summarised in Table 6 for males and females separately and together, by radon 23 
band over the eligible population, and totalled for England and Wales. In addition to the raw data, 24 
incidence standardised to the ONS 2010 and World Standard populations is also tabulated. 25 
4 Analysis of Results 26 
As discussed above, meta-analysis of an expanding portfolio of epidemiological studies indicates 27 
that the ERR of radon-induced lung-cancer exhibits linear-no-threshold dependence on mean radon 28 
  12  
exposure of the exposed population. If radon has a triggering role in the development of MS, then 1 
correlation might reasonably be assumed to exist between the incidence of the condition and the 2 
radon concentration level experienced by the exposed population, similar to that observed to exist 3 
between radon and lung-cancer. 4 
Using incidence data standardised to the ONS 2010 population (Table 6), ERR for MS due to radon 5 
exposure was calculated for each radon band, taking mean incidence for the full THIN population 6 
as normalising parameter. Results are plotted in Figure 6 (solid line). As the figure shows, no 7 
simple monotonic relationship exists between ERR and radon concentration; indeed Band 1, which 8 
has the lowest average radon level, exhibits relatively high MS incidence and ERR. The observed 9 
scatter is attributed to the small sample size. 10 
 11 
Figure 6: Excess relative risk for MS (standardised to England and Wales 2010 population)  by 12 
radon band 13 
 Heavy continuous line/circles (black): Experimental results from this study 14 
 Light continuous line (black): Linear fit from this study 15 
 Light dashed lines (black): 95% CI limits 16 
 Heavy chain-dashed line/diamonds (red): ERR vs radon for lung-cancer 17 
  (Darby et al., 2005) 18 
Linear regression of ERR against mean radon, plotted as the dashed black line in the figure, shows a 19 
positive gradient of 0.22 per 100 Bq·m-3 when forced to pass through the origin (representing a 20 
linear-no-threshold response), and 0.44 per 100 Bq·m-3 when unconstrained. The experimental data 21 
exhibit wide scatter (R2 = 0.25, p = 0.0961) and the fit is not statistically significant at 95% 22 
Confidence Interval. Statistical significance was not achieved by relaxing the criterion to 90%. Note 23 
that the line of best fit, the null hypothesis represented by the x-axis (y = 0) and the linear increase 24 
expected for radon-induced lung-cancer from the European case-studies (Darby et al., 2005) (chain-25 
dashed red line, 0.16 per 100 Bq·m-3) all lie inside the 95% Confidence Interval of the linear 26 
regression (Liengme, 2015) (light dotted hyperbolae). 27 
Pearson’s Chi-squared test was used to compare MS cases in the minimal radon band (Band 1: 44 28 
cases in 505,566 patient-years) with those for RAAs (Bands 2 to 9: 71 cases in 911,199 patient-29 
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years), yielding χ2 for the null hypothesis of 0.632 with continuity correction, 0.564 without 1 
continuity correction, and the difference in incidence between Band 1 and Bands 2 to 9 is therefore 2 
not statistically significant. Similar results were obtained when comparing males and females 3 
separately. 4 
The methodology employed here provides estimates of overall MS incidence similar to those 5 
provided by previous studies (Alonso et al., 2007; Mackenzie et al., 2014), as shown in Table 4. 6 
However, although the geographical spread of postcode sectors within each radon band contributes 7 
to ensuring that local non-uniformities of coverage are averaged on a band-by-band basis, the 8 
relatively low and non-uniform patient coverage by THIN in England and Wales (Table 5) ensures 9 
that insufficient data are currently available to confirm or refute the hypothesised correlation 10 
between MS incidence and radon concentration statistical significance. 11 
5 Discussion 12 
5.1 Study Design 13 
Domestic radon concentrations can exhibit extreme variability over relatively short geographical 14 
ranges, and these variations tend to be smoothed out as the size of the sampled locale increases. In 15 
the UK, domestic radon concentration levels are now known with high geographical resolution, the 16 
Radon Atlas for England and Wales providing data at the level of postcode sector, the average area 17 
of which is 22 km2. While this development, together with the advent of large computerised 18 
anonymised databases has facilitated the present investigation of the association between radon and 19 
MS incidence, the definitive demonstration of such an association would comprise a longitudinal 20 
case-control study, measuring radon in the homes of individual MS patients and controls and 21 
modelling their exposure, especially if they had previously moved house. This could be a complex, 22 
lengthy and expensive process, which might need to be international in scope and collaboration to 23 
recruit sufficient participants. 24 
A prime aim of the present study was to improve on the sensitivity of previous studies by directly 25 
accessing patient records in order to establish diagnoses, central to this objective being (a) the 26 
precision of diagnosis and recording into clinical notes by GPs and specialists and (b) the 27 
representative nature of the database derived from these notes and other data. Mackenzie et al. 28 
(2014) addressed the second of these issues, noting that a major strength of using an extraction 29 
database such as THIN is that it covers a representative sample of GPs, spread geographically, with 30 
a patient population broadly representative of that of the country as a whole. The present study 31 
population, 2.5 million patients tracked across a time-span of 8 years, provides greater statistical 32 
precision than that achievable through a regional survey, such as that recently reported by 33 
Neuberger et al. (2011). 34 
In addition to THIN, two further data extraction systems are in use in the UK. GPRD (now 35 
subsumed into Clinical Practice Datalink (CPRD) with an expanded source base) also interrogates 36 
Vision 360 systems, some practices contributing to both THIN and CPRD. QResearch (Hippisley-37 
Cox et al., 2004), formed as a partnership between EMIS and Nottingham University, accesses 38 
EMIS-based practices, around 50% of the UK total. Neither of these approaches full coverage of the 39 
clinical population, with both appearing to access comparable patient numbers to THIN. 40 
The representative nature of THIN data has been evaluated independently by comparing observed 41 
demographics, chronic condition prevalence, deprivation and deaths with UK national estimates 42 
(Blak et al., 2011), confirming that THIN can be generalised to the UK in terms of demographics 43 
and crude prevalence of major conditions, and that data collected outside GPRD appear as valid as 44 
the data collected within it (Herrett et al., 2010; Lewis et al., 2007). The principal weakness in the 45 
present methodology is the low penetration of data extraction from UK GP records, since the study 46 
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population results from the intersection of the two sparsely-populated geographical distributions, 1 
the RAAs and the extracted practices. Modelling of the penetration prior to commencement of the 2 
study failed to project the lack of patients in Band 9 (Cornwall), despite the relatively uniform 3 
distribution across the remainder of England and Wales. Although more radon results would 4 
improve the RAA mapping, the most important factor currently restricting the power of this 5 
analysis is the modest percentage of the population accessed by THIN. 6 
The Health and Social Care Act 2012 requires GP practices to provide information to the Health 7 
and Social Care Information Centre in specified circumstances, and authorises NHS England, the 8 
body responsible for managing public health services in England, to extract this data, along with 9 
data collected by the Hospital Episodes Statistics service, to provide an integrated data service, 10 
known as Care.Data. This builds on existing data services, linking GP and hospital records for the 11 
first time, eventually expanding to cover all care settings, both in and outside of hospital, and will 12 
extract data from all GP databases, not just from those choosing to opt in to an existing proprietary 13 
scheme. Although currently in its pilot phase, eventual full nationwide roll-out is anticipated to 14 
provide a future opportunity to repeat this study with a database potentially 20 times larger than that 15 
explored here, with correspondingly enhanced statistical confidence. 16 
5.2 Confounding Factors 17 
In interpreting the study results, a number of potential confounding factors require consideration. 18 
5.2.1 Vitamin D and Exposure to Sunlight  19 
There is clear evidence that reduced exposure to sunlight, and the consequent lack of vitamin D, 20 
increases MS risk. Meta-analysis of 321 studies (Simpson et al., 2011) found significant positive 21 
association (change in prevalence per degree-latitude) between age-standardised prevalence (1.04, 22 
p<0.001) and latitude, diminishing at high latitudes; adjustment for prevalence year strengthened 23 
the association with latitude (2.60, p<0.001). The persistence of a positive gradient in Europe after 24 
adjustment for HLA-DRB1 allele frequencies strongly supports a role for latitude-dependent 25 
environmental factors, the most prominent candidates being ultraviolet-B (UV-B) radiation and 26 
Vitamin D. Mackenzie et al. (2014) note (a) that significant (p<0.001) variations in incidence and 27 
prevalence exist between different regions of the UK and (b) that, despite the difference in MS 28 
incidence between Scotland and the England, no statistically significant trend with latitude exists 29 
within the twelve English regions. 30 
Using a publicly-accessible tabulation of postcode coordinates6, the geographical centroids of the 31 
sets of postcode sectors comprising the individual radon bands were determined, a further publicly-32 
accessible data tool7 being used to model the mean annual UV-B irradiation at each band centroid. 33 
Bands 1 to 7 have relatively wide spatial distribution, standard deviations for latitude and longitude 34 
of their sets of postcode sector centroids being around 1.2 and 1.4 degrees (132 km and 94 km at 35 
latitude 52 degrees) respectively. Band 8 is largely (18 of 27 sectors) located in south-west England, 36 
with the remainder located in Oxfordshire (two sectors) and the Peak District (seven sectors), and 37 
Band 9 (contributing no MS cases to the study) is entirely so, with significantly smaller centroid 38 
standard deviations. Geographical centroids of the bands migrate in a consistent south-westerly 39 
direction from Gloucester (Band 1) to Lynmouth, Devon (Band 8) and to Redruth, Cornwall 40 
(Band 9) a distance of approximately 300 km. Along this track, annual UV-B irradiation increases 41 
linearly (R2 = 0.81) from 27.7 kJ·m-2 in Band 1 to 31.0 kJ·m-2 in Band 9. Bands 1 to 7 show reduced 42 
                                                            
6 PostcodePal – Database Generator: Vulcan Logix UK Ltd, 145-157 St. John Street, London EC1V 4PW, UK. Online 
at http://www.postcodepal.com/?page=database-generator 
7 SoDa - Integration and exploitation of networked solar radiation databases for environment monitoring. European 
Commission, Contract IST-1999-12245 (2000 – 2003). Calculation tool online at http://www.soda-is.com. 
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UV-B irradiation range of 27.7 – 28.4 kJ·m-2; for the present study, therefore, UV-B irradiation can 1 
be regarded as geographically invariant except over the limited area encompassed by Bands 8 and 9, 2 
and can be discounted as a first order confounding factor. 3 
In addition to the general latitudinal UV exposure gradient, variation in time spent indoors, sun-4 
bathing, use of tanning studios and vitamin pill consumption will affect individual vitamin D levels. 5 
Increased time indoors will also increase overall radon dose, and it has been postulated that, if a link 6 
to radon exposure exists, this might explain increased MS incidence in women (Eidbo and Prater, 7 
2004). At the level of the present study, however, these effects could not be quantified and a 8 
countrywide uniformity was therefore assumed. 9 
5.2.2 Tobacco Smoking 10 
Recent reviews confirm association between cigarette smoking and MS onset, with ERR of 0.4 - 0.8 11 
among smokers (Hedstromm et al., 2013; Jafari and Hintzen, 2011; Wingerchuk, 2012). In 12 
England, smoking prevalence is highest in the major conurbations (London, Manchester, Liverpool 13 
and Leeds-Bradford), all predominantly low-radon areas in Bands 0 and 1. Denman et al. (2014) 14 
analysed smoking prevalence and the percentage of houses above the radon action level in English 15 
local authorities, reporting no correlation between these parameters (R = -0.05). Since similar 16 
geographical considerations apply with regard to tobacco smoking as to UV exposure, it is 17 
anticipated that, given the widespread distribution of postcode sectors within each radon band, 18 
geographical variations in smoking prevalence can be disregarded in the present analysis. 19 
5.2.3 Physical Trauma 20 
It has long been felt that physical trauma, particularly involving the spinal cord and/or the brain, 21 
could disrupt the blood–brain barrier, leading to the development of MS plaques in those who are 22 
already genetically at risk (Poser, 2000). In a recent meta-analysis (Lunny et al., 2013) of 36 high-23 
quality case–control studies and four cohort studies, the former indicated statistically significant 24 
association between premorbid head trauma and risk for developing MS. With one exception, where 25 
significant brain injury within the last six years was reported to double MS incidence (Kang et al., 26 
2012), this correlation was absent in the cohort studies. Although interactions of this nature were 27 
not sought in this study, it is anticipated that their incidence would be relatively low and will not 28 
significantly influence the results. 29 
5.2.4 Ethnicity and Social Deprivation 30 
Although Ramagopalan et al. (2010) noted that studies controlling for confounding factors, e.g. the 31 
US Veterans series (Kurtzke et al., 1979), showed lower MS prevalence in a number of non-32 
Caucasian races/nationalities, recent studies in the USA (Langer-Gould et al., 2013) question the 33 
widely accepted assertion that black males have a lower risk of MS than whites. In England and 34 
Wales, immigrant non-Caucasian ethnic groups have historically concentrated in cities where, as 35 
already noted, radon levels are generally low (Bands 0 and 1), where the 50-measurement criterion 36 
excludes many postcode sectors from analysis (Band 0), and where genetic disposition to MS is 37 
below average (Hedstrom et al., 2013). Ramagopalan et al. (2011) observe that the pattern of UV-B 38 
and MS is confounded in large metropolitan areas (Merseyside, Manchester, Leeds, Birmingham 39 
and London), geographically-weighted regression showing these regions to be two standard 40 
deviations below the main trend. 41 
The Database Managers report (Blak et al., 2011) that THIN has a higher proportion of patients 42 
living in the most affluent areas than the national average, with 23.5% of its subjects resident in the 43 
least deprived Townsend quintile (Townsend et al., 1988). This is likely to be related to deprivation 44 
in inner cities which, as discussed, tend to exhibit low radon levels and therefore contribute 45 
minimally to the results presented here. 46 
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No bias is therefore expected from either of these confounders. 1 
5.2.5 Radon Band Allocation 2 
While the Radon Atlas gave values for the average radon level in postcode sectors where 10 or 3 
more houses had been tested, the study protocol only collected data from postcode sectors where 4 
more than 50 houses had been tested. This ensured that the calculated average radon level for the 5 
postcode was more closely indicative of the actual average of the sector.  6 
A consequence of the study protocol was that residents of homes where radon remediation had 7 
already been carried out, and where radon levels had consequently been reduced, could not be 8 
corrected for or excluded from consideration. The HPA confirm8 that radon concentrations reported 9 
in the various Radon Atlases represent the first measurement from each house tested; in the vast 10 
majority of cases, these can therefore be assumed to represent the situation prior to any remediation 11 
that might have been carried out. Since remediated houses have lower radon concentrations than 12 
unremediated houses, the cumulative radon exposure for any radon band where some patients lived 13 
in remediated houses would therefore be expected to be less than that derived from calculating the 14 
exposure from the mean of the radon levels in each postcode sector. 15 
However, response to successive campaigns to test and remediate homes has been modest, at best. 16 
Only 40% of householders in the original RAAs have had their homes tested, and of those finding 17 
radon levels exceeding the Action Level, only 15% have taken remedial action (Denman et al., 18 
2013). In Band 9, where 50% of homes exceed the Action Level, this represents just 3% of all 19 
houses, while for Band 8, it is 1.8%. For Bands 7 and below, the maximum percentage of houses 20 
remediated is below 1%. It is therefore unlikely that this effect will significantly influence the 21 
results. 22 
5.2.6 Population Mobility 23 
On average, during the period covered by the study data, 46% of the UK population lived in the 24 
same house for over 15 years and 25% for more than 30 years (DCLG, 2009). Conversely, 35% of 25 
the population moved house within five years, although 60% of movers stayed within a five-mile 26 
radius of their last property and 23% moved less than one mile. Even this restricted mobility, 27 
however, can potentially confound the analysis since, as noted above, the causative exposure for 28 
radon-induced lung-cancer could be up to five years before disease onset. The study population was 29 
therefore restricted to patients registered at their GP practice for at least five years prior to the 30 
commencement of the analysis period. While this condition necessarily impacts patient numbers in 31 
the more-mobile 20 – 30 year age group, population standardisation effectively compensates for 32 
this. It should be noted that this criterion does not exclude patients who moved home, but remained 33 
registered with their original GP.  34 
The similarity of this study’s estimate of overall MS incidence to those of previous UK studies 35 
(Alonso et al., 2007; Mackenzie et al., 2014) (c.f. Table 4) suggests that using a population subset 36 
with lower mobility has not introduced any bias. 37 
6 Conclusions 38 
Although attention has hitherto been focussed on environmental radon gas in the context of its 39 
causative role in lung-cancer, a growing body of evidence suggests that radon may be implicated in 40 
the initiation of other conditions, recent studies indicating a possible causative link between 41 
elevated levels of environmental (particularly domestic) radon gas and increased MS incidence. To 42 
test this hypothesis, a retrospective study was performed of MS incidence among the population of 43 
                                                            
8 Private communication to CJGK, 2005 
  17  
England and Wales resident in those areas of elevated domestic radon concentration classified as 1 
Radon Affected Areas (RAAs), using the clinical extraction database maintained by The Health 2 
Improvement Network (THIN). This contains the electronic medical records of 12.4 million patients 3 
(3.6 million active patients) equivalent to 75.6 million patient years of data collected from 587 4 
general practices in the UK, covering 5.7% of the UK population. 5 
The study population, 20,140,498 person-years of clinical monitoring, represents a mean annual 6 
population over the eight-year study period of around 2.5 million individuals, equally divided 7 
between males and females. During this period, 1,512 new MS cases were diagnosed, females 8 
(1,065 cases) outnumbering males (441 cases) by nearly 2.5 times, equivalent to raw incidence rates 9 
of 7.51, 10.61 and 4.40 per 105 person-years respectively, comparable to previous studies. 10 
Of the 1,512 new cases, 115 were reliably allocated to one of the radon bands representing areas 11 
located in RAAs. Standardising raw data to the 2010 England and Wales age profile, ERR figures 12 
for MS were calculated for each radon band, using the mean MS incidence for the full population as 13 
normalising parameter. No simple monotonic relationship is apparent between MS incidence and 14 
radon concentration and the data exhibit wide scatter (R2 = 0.25). Linear regression of ERR against 15 
mean band radon concentration shows a positive gradient of 0.22 per 100 Bq·m-3 when forced to the 16 
origin (representing linear-no-threshold response), comparable to that reported for lung-cancer (0.16 17 
per 100 Bq·m-3 (Darby et al., 2005) and hinting at a possible common mechanism for the triggering 18 
process. Most of the plotted points fall between the 95% Confidence Limits for the linear fit, as also 19 
do the null hypothesis represented by the x-axis (y = 0.0) and the linear increase expected for radon-20 
induced lung-cancer, and although a trend of increasing MS incidence with increasing radon 21 
concentration has been identified, the correlation is not statistically significant. 22 
On the basis of the evidence available, and despite the geographical spread of postcode sectors 23 
within each radon band, the relatively low and non-uniform patient coverage by THIN renders 24 
insufficient data available for a statistically significant conclusion to be drawn, and the hypothesis 25 
that mean radon concentration in a RAA is a predictor of the incidence of MS is consequently not 26 
proven. It is anticipated that the forthcoming Care.Data service, linking GP and hospital records 27 
with universal scope, will provide a future opportunity to repeat this study with a database 28 
significantly larger than that explored here, with correspondingly enhanced statistical power.  29 
As noted above, the definitive demonstration of association between radon and MS incidence would 30 
comprise a longitudinal case-control study, measuring radon in the homes of individual MS patients 31 
and controls. This might need to be international in scope and collaboration to recruit sufficient 32 
participants. Our study may not have generated a sufficiently interesting result to justify such a 33 
major investigation, but it does justify further repeat investigations, either using a larger UK patient 34 
database, or considering regions with higher indoor radon levels. 35 
Numerous campaigns to monitor domestic radon levels, and to encourage remediation where high 36 
levels are discovered, have been undertaken, the prime motivation being the reduction in the overall 37 
population risk of lung-cancer. However, the response to these campaigns to date has been 38 
moderate, with positive action being generally greatest among the sections of the population least at 39 
risk of lung-cancer. Recognition of the linkage between radon and other conditions contributing 40 
significantly to the overall health burden has the potential to bring additional, hitherto unrecognised, 41 
health benefits, with the associated publicity potentially increasing the likelihood of the public 42 
taking action to reduce domestic radon levels and making remediation campaigns correspondingly 43 
more cost-effective. 44 
Finally, although a limited number of ecological studies on MS have been reported, no similar 45 
investigations appear yet to have been undertaken on the other neurological conditions in which 46 
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radon has previously been incriminated, viz. Alzheimer's and Parkinson's diseases and motor 1 
neurone disease. With radon concentration data for England, Wales, Northern Ireland and much of 2 
Scotland now becoming available at increasing geographical resolution, and with the increasing 3 
availability of integrated clinical data record systems such as THIN, CPRD and, imminently, 4 
Care.Data, the opportunity now presents itself to initiate further studies of this nature. 5 
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11 Tables 1 
Table 1: Definition of radon Bands 1 - 9, with corresponding numbers of postcode sectors and 2 
included homes, with arithmetic (AM) and geometric (GM) mean indoor radon levels, 3 
calculated from Green et al. (2002). 4 
Band 
 
Postcode 
Sectors 
Homes THIN 
Population 
2005-2012 
[person-
years] 
Weighted Mean 
Radon [Bq·m-3] 
Homes projected to exceed 
Action Level 
Total Tested AM GM Total Definition 
% > A.L. 
Actual 
% > AL 
1 202 638390 55282 505522 36 27 224 <=1.0 0.41 
2 93 263070 33281 157275 47 32 515 1.1 - 2.0 1.55 
3 133 355960 67067 267162 58 39 2282 2.1 - 5.0 3.40 
4 115 278270 70689 192725 80 52 5286 5.1 - 10.0 7.48 
5 74 179990 52337 119988 106 66 6567 10.1 - 15.0 12.55 
6 39 97890 31672 83356 127 80 5428 15.1 - 20.0 17.14 
7 46 103770 32468 46983 160 99 7790 20.1 - 30.0 23.99 
8 27 53990 18980 43639 218 127 6554 30.1 - 40.0 34.53 
9 14 26530 9080 14 312 201 4790 >40.0 52.75 
Band 1-9 743 1997860 370856 1416650 73 63 39436  10.63 
 5 
Table 2: Read Codes used in data extraction 6 
Read Code Description 
666A.00 Multiple sclerosis review 
666B.00 Multiple sclerosis multidisciplinary review 
8CS1.00 Multiple sclerosis care plan agreed 
9kG..00 Special Services for patient with multiple sclerosis – enhanced service administration 
F20..00 Multiple sclerosis 
F20..11 Disseminated sclerosis 
F200.00 Multiple sclerosis of the brain stem 
F201.00 Multiple sclerosis of the spinal cord 
F202.00 Generalised multiple sclerosis 
F203.00 Exacerbation of multiple sclerosis 
F20z.00 Multiple sclerosis NOS 
ZRVE.00 Kurtzke multiple sclerosis rating scale 
ZRVE.11 Kurtzke multiple sclerosis scale 
 7 
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Table 3:  Raw extracted data and calculated incidence rate per 105person-years for England and 1 
Wales combined, in standard age-bands 2 
 (a): Full population (Bands 0 – 9) 3 
 
MS Cases Person-Years MS Incidence [10-5] 
Age Female Male Both Female Male Both Female Male Both 
0–14  3 1 4 1,109,208 1,173,131 2,282,339 0.27 0.09 0.18 
15–19  15 7 22 591,476 675,608 1,267,084 2.54 1.04 1.74 
20–24  27 23 50 438,921 564,489 1003,410 6.15 4.07 4.98 
25–29  58 23 81 405,197 498,611 903,808 14.31 4.61 8.96 
30–34  91 36 127 486,577 522,709 1,009,286 18.70 6.89 12.58 
35–39  150 53 203 667,870 673,230 1,341,100 22.46 7.87 15.14 
40–44  169 77 246 832,750 830,303 1,663,053 20.29 9.27 14.79 
45–49  178 63 241 851,240 858,599 1,709,839 20.91 7.34 14.09 
50–54  135 52 187 771,590 788,267 1,559,857 17.50 6.60 11.99 
55–59  102 36 138 750,967 760,526 1,511,493 13.58 4.73 9.13 
60–64  78 38 116 749,137 747,803 1,496,940 10.41 5.08 7.75 
65–69  36 17 53 627,071 604,729 1,231,800 5.74 2.81 4.30 
70–74  13 6 19 538,073 491,167 1,029,240 2.42 1.22 1.85 
75–79  8 6 14 473,091 392,496 865,587 1.69 1.53 1.62 
80–84  4 3 7 381,095 270,477 651,572 1.05 1.11 1.07 
85+ 3 1 4 409,607 204,483 614,090 0.73 0.49 0.65 
Total 1070 442 1512 10,083,870 10,056,628 20,140,498 10.61 4.40 7.51 
 4 
 (b): Validated residents of Bands 1 - 8 5 
 
MS Cases Person-Years MS Incidence [10-5] 
Age Female Male Both Female Male Both Female Male Both 
0–14  0 0 0 79,613 84,366 163,979 0.00 0.00 0.00 
15–19  1 0 1 42,529 49,719 92,248 2.35 0.00 1.08 
20–24  3 1 4 30,017 40,699 70,716 9.99 2.46 5.66 
25–29  4 4 8 25,502 33,565 59,067 15.69 11.92 13.54 
30–34  4 0 4 30,709 34,374 65,083 13.03 0.00 6.15 
35–39  13 5 18 42,379 43,943 86,322 30.68 11.38 20.85 
40–44  15 6 21 55,939 57,832 113,771 26.81 10.37 18.46 
45–49  13 5 18 59,637 62,271 121,908 21.80 8.03 14.77 
50–54  10 2 12 54,070 56,834 110,904 18.49 3.52 10.82 
55–59  8 6 14 51,743 53,290 105,033 15.46 11.26 13.33 
60–64  5 3 8 54,313 54,836 109,149 9.21 5.47 7.33 
65–69  4 1 5 47,369 46,941 94,310 8.44 2.13 5.30 
70–74  0 1 1 38,348 35,943 74,291 0.00 2.78 1.35 
75–79  0 0 0 32,657 28,012 60,669 0.00 0.00 0.00 
80–84  0 1 1 26,164 19,241 45,405 0.00 5.20 2.20 
85+ 0 0 0 28,955 14,840 43,795 0.00 0.00 0.00 
Total  80 35 115 699,944 716,706 1,416,650 11.30 4.67 7.89 
 6 
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Table 4: MS incidence (this study and recent UK Studies) for the catchment population. 1 
Study Geographical Scope Time Frame 
MS 
Cases 
MS Incidence [10-5] 
Female Male Both 
This study 
England & Wales [Raw] 
2005 -
2012 1512 
10.61 4.40 7.51 
England & Wales [UK 2010] 11.43 4.88 8.12 
England & Wales [World 1960] 11.80 4.77 8.12 
Mackenzie et al. 
(2014) UK 
1990 -
2010 1320 11.52 4.84 9.64 
Alonso et al. (2007) 
UK [Raw] 1993 -
2000 642 
7.42 3.44 5.47 
UK [World 1960] 7.16 3.07 5.10 
 2 
Table 5: Radon bands – population and coverage. Assumes household size 2.47 3 
Radon Band 
Mean 
Band 
Radon 
MS Cases 
(2005-
2012) 
THIN Population 
(2005-2012) 
[person-years] 
2002 Radon 
Atlas 
Population  
Coverage 
1 36 44 505,522 1,589,173 3.98% 
2 47 10 157,275 658,675 2.98% 
3 58 19 267,162 880,802 3.79% 
4 80 13 192,725 684,610 3.52% 
5 106 8 119,988 450,503 3.33% 
6 127 11 83,356 241,788 4.31% 
7 160 7 46,983 249,396 2.35% 
8 218 3 43,639 149,410 3.65% 
9 312 0 14 56,390 0.00% 
Total (1 – 9) 73 115 1,416,650 4,960,747  
0  1397 18,152,817 Not included in radon analysis 
All  1512 19,569,467 49,662,100 5.07% 
 4 
  27  
Table 6: MS incidence by radon band for England and Wales: 1 
(a) Raw incidence 2 
(b) Incidence standardised to England and Wales 2010 population (ONS, 2011) 3 
(c) Incidence standardised to World Standard Population (Bray, 2002) 4 
Radon 
Band 
Mean Radon 
Level 
[Bq·m-3] 
Female Male Both 
Cases Incidence 10-5 Cases 
Incidence 
10-5 Cases 
Incidence 
10-5 
(a) Raw Incidence 
1 36 31 12.33 13 5.12 44 8.70 
2 47 6 7.72 4 5.03 10 6.36 
3 58 10 7.64 9 6.61 19 7.11 
4 80 9 9.39 4 4.13 13 6.75 
5 106 7 11.95 1 1.63 8 6.67 
6 127 8 19.53 3 7.08 11 13.20 
7 160 7 30.34 0 0.00 7 14.90 
8 218 2 9.36 1 4.49 3 6.87 
9 312 0 0.00 0 0.00 0 0.00 
1-9 73 80  35  115  
0-9 124 1070 10.60 442 4.40 1512 7.50 
(b) Standardised to England and Wales 2010 Population (Bray, 2002) 
1 36 
 
12.39 
 
4.47 
 
8.85 
2 47 
 
8.31 
 
6.76 
 
6.36 
3 58 
 
6.36 
 
7.63 
 
6.32 
4 80 
 
9.58 
 
3.93 
 
6.44 
5 106 
 
10.74 
 
1.40 
 
5.87 
6 127 
 
19.99 
 
11.33 
 
12.54 
7 160 
 
30.25 
 
0.00 
 
14.40 
8 218 
 
14.47 
 
16.05 
 
9.17 
9 312  0.00  0.00  0.00 
0-9 73 
 
10.24 
 
4.16 
 
7.17 
(c) Standardised to World Standard Population (Segi, 1960) 
1 36 
 
11.11 
 
4.94 
 
8.00 
2 47 
 
7.59 
 
3.75 
 
5.47 
3 58 
 
4.95 
 
4.92 
 
4.98 
4 80 
 
8.54 
 
2.56 
 
5.39 
5 106 
 
8.67 
 
0.88 
 
4.65 
6 127 
 
18.09 
 
4.82 
 
10.70 
7 160 
 
27.09 
 
0.00 
 
12.52 
8 218 
 
15.86 
 
5.31 
 
9.12 
9 312  0.00  0.00  0.00 
0-9 73 
 
8.97 
 
3.55 
 
6.06 
 5 
 6 
